Business
MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results
MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results Canada NewsWire...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n \n \n \n MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n May 10, 2023\n \n \n /CNW/ -\n \n MediPharm Labs Corp.\n \n (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the three month period ended\n \n March 31, 2023\n \n , before markets open on\n \n Monday, May 15, 2023\n \n .\n \n \n \n \n \n \n \n \n \n MediPharm's executive management team will also host a conference call and audio webcast on\n \n Monday, May 15, 2023\n \n at\n \n 8:30 a.m. eastern time\n \n to discuss the Company's financial results.\n \n \n \n Audio Conference Call Dial in Details:\n \n \n \n Toll-free number: +1 (888) 330-2454 / International number: +1 (240) 789-2714\n \n \n Conference ID: 4921762\n \n \n Participants are asked to dial in approximately 15 minutes before the start of the call.\n \n \n \n Audio Webcast:\n \n \n \n An audio webcast will be available by visiting the following link\n \n here\n \n .\n \n \n For those who are unable to participate on the live conference call or webcast, a replay will be available at\n \n https://www.medipharmlabs.com/investors\n \n approximately one day after completion of the call.\n \n \n \n About MediPharm Labs\n \n \n \n Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its c...